Second Genome welcomes Mohan S. Iyer to the team. As SVP of Corporate Development, Mohan is responsible for building relationships and working with our partners, including biopharma and nutrition companies, to identify novel biomarkers for classifying patient populations and to assess the impact of novel microbiome-modulating products.
Second Genome welcomes Mohan S. Iyer to the team. As SVP of Corporate Development, Mohan is responsible for building relationships and working with our partners, including biopharma and nutrition companies, to identify novel biomarkers for classifying patient populations and to assess the impact of novel microbiome-modulating products. Mohan has over 25 years experience in the life sciences industry in a range of functions at Genentech, diaDexus, and most recently as CBO and CFO at Tethys Bioscience. He also brings experience as a management consultant, at The Wilkerson Group, and as an investment banker, at Burrill & Company. He holds an BS in Chemical Engineering from University of Tennessee, an MS in Biomedical Engineering from Duke, and an MBA from Yale University.